Exelixis (EXEL) Net Income (2010 - 2026)
Exelixis' Net Income was $212.05 million in Q2 2027, up 14.7% from $184.85 million a year earlier and up 0.8% from the prior quarter.
Powered by 
Analysis
Exelixis (EXEL) Net Income (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Exelixis' Net Income was $860.62 million through Jul 3, 2026, up 42.9% year-over-year; for FY2026, it came in at $782.57 million, up 50.1% from FY2025.
- Net Income shows a five-year compound annual growth rate of 27.6% (FY2021 to FY2026).
- In earlier years, Net Income was $521.27 million in FY2025, $207.77 million in FY2023 (+14.0%) and $182.28 million in FY2022 (-21.1%).
- Quarterly Net Income has moved between $37.32 million (Q1 2025) and $244.53 million (Q4 2026) over five years.
- Compared with a year earlier, Net Income has increased for four straight quarters, with growth averaging 82.5% over the last six quarters.
- Per Business Quant data, EXEL's Net Income in the three quarters before Q2 2027 was $210.47 million (Q1 2027), $244.53 million (Q4 2026) and $193.58 million (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.51 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -237.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Exelixis | 14.54 Bn | 10.87 Bn | 608.03 Mn | 212.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 212.05 Mn |
| Apr 3, 2026 | 210.47 Mn |
| Jan 2, 2026 | 244.53 Mn |
| Oct 3, 2025 | 193.58 Mn |
| Jul 4, 2025 | 184.85 Mn |
| Apr 4, 2025 | 159.62 Mn |
| Jan 3, 2025 | 139.86 Mn |
| Sep 27, 2024 | 117.97 Mn |
| Jun 28, 2024 | 226.12 Mn |
| Mar 29, 2024 | 37.32 Mn |
| Dec 29, 2023 | 85.52 Mn |
| Sep 29, 2023 | 1.04 Mn |
| Jun 30, 2023 | 81.18 Mn |
| Mar 31, 2023 | 40.03 Mn |
| Dec 30, 2022 | -30.17 Mn |
| Sep 30, 2022 | 73.21 Mn |
| Jul 1, 2022 | 70.67 Mn |
| Apr 1, 2022 | 68.57 Mn |
| Dec 31, 2021 | 95.17 Mn |
| Oct 1, 2021 | 38.20 Mn |
API Access
Exelixis Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=EXEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();